- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/545 - Embryonic stem cellsPluripotent stem cellsInduced pluripotent stem cellsUncharacterised stem cells
Patent holdings for IPC class A61K 35/545
Total number of patents in this class: 1425
10-year publication summary
|
97
|
149
|
142
|
118
|
140
|
120
|
151
|
128
|
96
|
62
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20745 |
46 |
| Kyoto University | 2904 |
33 |
| FATE Therapeutics, Inc. | 235 |
28 |
| Tohoku University | 2980 |
28 |
| Osaka University | 3267 |
20 |
| The Board of Trustees of the Leland Stanford Junior University | 6653 |
16 |
| Healios K.K. | 105 |
15 |
| President and Fellows of Harvard College | 6094 |
14 |
| CRISPR Therapeutics AG | 367 |
14 |
| Memorial Sloan-Kettering Cancer Center | 2043 |
13 |
| Riken | 1717 |
13 |
| Life Science Institute, Inc | 51 |
13 |
| RACTHERA Co., Ltd. | 123 |
13 |
| Minovia Therapeutics Ltd. | 51 |
11 |
| University of Washington | 2448 |
11 |
| The Johns Hopkins University | 5882 |
10 |
| Cedars-Sinai Medical Center | 1203 |
10 |
| Sumitomo Dainippon Pharma Co., Ltd. | 211 |
10 |
| ViaCyte, Inc. | 180 |
10 |
| I Peace, Inc. | 118 |
10 |
| Other owners | 1087 |